Synthetic DNA, Genomics, and Biotech Solutions by Twist Bioscience

Twist Bioscience announced high-resolution MHC haplotyping with long-read hybrid capture. Twist Bioscience conveyed thanks for the use of its DNA products in this work.A link to the medRxiv ...

Twist Bioscience is asking its followers to share which sample type they find most challenging in their NGS Library Prep workflow.The company offered four options: cfDNA (liquid biopsy), FFPE ...

Twist Bioscience supported a high-resolution MHC haplotyping project with its long-read hybrid capture technology. The stock was referenced in connection with this development.Twist Bioscience ...

Twist Bioscience says its RNA sequencing solutions offer higher efficiency for those with budget constraints.Twist Bioscience states users can maximize data per run and reduce sequencing volume ...

Twist Bioscience will participate in ESHG 2026 in Gothenburg. The company announced its involvement on social media.Twist Bioscience will be present at Booth 508 and host a lunch session on ...

Twist Bioscience took part in the Berlin Bio x AI Hackathon, where it engaged with participants and shared its support for the biological research continuum. The company described its expertise ...

Twist Bioscience has introduced an on-demand webinar library featuring expert-led sessions on key topics in life sciences. The library covers areas such as artificial intelligence applications ...

Twist Bioscience reports that AAlphaBio is using Gene Fragments and Pooled DNA to generate vast, high-quality wet-lab datasets to train its AlphaBind AI model. This new approach enables the rapid ...

Twist Bioscience celebrates Pi Day by highlighting its rapid gene synthesis capabilities and advanced technologies. The company outlines the ability to express genes in as fast as 4 days for ...

Twist Bioscience reports that AI engineering has enabled the creation of synthetic homologs of potentially dangerous biological sequences which can evade existing biosecurity screening systems by ...

Twist Bioscience is advancing research into engineered immune cells aimed at enabling a potential cure for type 1 diabetes. The company’s new approach leverages cutting-edge synthetic biology ...

Twist Bioscience announces the return of their popular print-at-home Valentine offerings aimed at scientists and lab workers. These themed Valentines are designed to celebrate the scientific ...

Twist Bioscience announced its support for a significant research project led by several prominent scientists, including Charles Swanton from The Crick and University College London, and involving ...

Stanford Health Care is advancing its pharmacogenomics initiative known as SPIRA into primary care. The expansion leverages long-read sequencing technology provided by Twist Bioscience along with ...